---
artifact:
  type: product-owner-signoff
  from: Product Owner SubAgent
  to: MOD-W Moderator
  date: 2026-10-01
  review_artifacts:
    - mod-w/product.md
    - mod-w/step-02.md
    - prod-w/evidence-knowledge-model.md
    - mod-w/architecture.md
    - mod-w/reviews/TECH-LEAD-REVIEW-STEP-02.md
    - mod-w/reviews/MODERATOR-REVIEW-STEP-02.md
    - mod-w/reviews/qa.md
    - prod-w/protocol-semantics.md (partial: Sections 4.4 / action catalog ACT-01 to ACT-07, authority table, PR-26; used only to check conflicts)
  review_status: SIGNED_OFF_WITH_CONDITIONS
---

# Product Owner Sign-off: STEP-02 (Phase 3c)

**Reviewer role:** Product Owner SubAgent (MOD-W Phase 3c)
**Date:** 2026-10-01
**Question answered:** Does the STEP-02 deliverable satisfy the *acceptance intent* of the accepted Product Definition (`mod-w/product.md` v1.1), not only the literal checkboxes in `mod-w/step-02.md`?

---

## 0. Standing of this document (read first)

- This is a **recommendation about acceptance intent only.** I am not the MOD-W Moderator.
- It does **not** ratify `mod-w/reviews/qa.md` as Phase 3b, waive any gate, dispose of the pending domain terms (`mod-w/domain-language.md`), dispose of MW-OBS-011/012, record the MW-ADAPT-001 re-evaluation, or accept anything on the Moderator's behalf.
- It does **not** cure defect D-01 in `qa.md`. STEP-02 was recorded as accepted (`mod-w/reviews/MODERATOR-REVIEW-STEP-02.md`, 2026-09-30) before 3b and 3c ran. This sign-off is produced after acceptance; it is a late input, not a pre-acceptance gate. Whether to ratify 3b/3c retroactively or record a STEP-02 waiver remains a Moderator decision.
- **Independence caveat.** I am a Claude-family subagent. I do not know the Development Team's exact producing configuration, but the model's own rule (EKR-12, PR-28 as cited at `prod-w/evidence-knowledge-model.md:433`) says a different configuration of the same vendor/role is not independent corroboration. Weigh this sign-off as one reviewer's findings, not as independent validation.
- I was given `qa.md`, the Tech Lead review, and the Moderator review as inputs, so I am not blind to them. The judgments below are mine; where I agree with QA I say so.

### What I read, and what I did not

Read in full: `mod-w/product.md`, `mod-w/step-02.md`, `prod-w/evidence-knowledge-model.md` (lines 1 to 1048), `mod-w/architecture.md`, `TECH-LEAD-REVIEW-STEP-02.md`, `MODERATOR-REVIEW-STEP-02.md`, `qa.md`.
Read in part: `prod-w/protocol-semantics.md`, action catalog (lines 236 to 275), authority table via search (line 138, PR-26 at line 408). I did not re-read the rest of it.
Not read: `mod-w/domain-language.md`, `research/mod-w-transferability/observations.md`, `adaptations.md`, `roadmap.md`, STEP-01 review artifacts. Claims about those come from `qa.md` and the model's own text and are marked as such. I did not run git commands or verify the git-history claims in `qa.md`.

---

## 1. Recommendation

**SIGNED_OFF_WITH_CONDITIONS.**

The content satisfies the acceptance intent of the Product Definition. It is strongest exactly where the Product Definition's failure pattern is strongest. I found no weakening of human authority or self-approval invalidity. I did find one self-approval-adjacent gap that the model leaves implicit (Condition B-1), and I advise the Moderator to keep the sign-off tied to the gate-record decisions in Condition B-2. No model rewrite is requested.

---

## 2. Answers to the five questions

### 2.1 Does the model address the core problem? Strong and thin spots

The Product Definition's core problem is that plausible ideas, weak evidence, agent agreement, and inherited assumptions accumulate into unjustified confidence (`product.md:23`, failure pattern `product.md:68-78`). The model states this as its own job (`evidence-knowledge-model.md:37`) and mostly delivers.

**Strong**

| Failure-pattern element | How the model meets it | Where |
| --- | --- | --- |
| Agent agreement counted as validation | Agreement has "no evidentiary standing"; evidence must have a source traceable independently of any actor's assertion about the target; model-generated output with no followable source is a claim/inference/advisory finding, not evidence. This is the sharpest single move in the artifact and matches PE-2 in intent, not only in wording. | 7.1 (358-369), 7.6 (424-435), EKR-13, EKR-17 |
| Inference and fact conflated | Inference never evidence; derived vs evidential support must be distinguishable; AI synthesis is captured as "an inference from cited material" by an identified configuration. Value judgments are marked evaluative rather than given a new class. | 9.1, 9.2, EKR-26 to EKR-28 |
| Counter-evidence and failed searches disappear | Counter-evidence is evidence with the same elements; negative findings need an attempt record so an absence inference can be judged; a decision must cite the opposition recorded against its basis. | 7.4, 7.5, 9.4, EKR-15, EKR-16, EKR-30 |
| Inherited assumptions go invisible | Every assumption is recorded whether or not material; a relied-on unvalidated hypothesis keeps its classification and every dependency on it is marked as reliance under assumption. FR-7's four conditions each become a record requirement. | 8.4, EKR-22, EKR-23 |
| Decisions stay "silently valid" | Dependency links, presumed materiality for anything a consequential decision cites, trigger catalog, exposure, and "current validity is not historical acceptance". | 10.1 to 10.9, EKR-33 to EKR-40 |
| Hidden uncertainty / false precision | No score, weight, or grade is defined; uncertainty lives in limitations statements and visible challenges. | 7.9, EKR-19, EKR-41 |
| Overclaiming | Section 1.4 and 7.7 state plainly that suppression of unfavorable information cannot be made impossible, only invalid-to-ignore once recorded. This honesty is a product strength (GR-4 spirit). | 66-68, 437-446 |

**Thin or only partly addressed**

1. **Alternative hypotheses.** The failure pattern lists "alternative hypotheses and counter-evidence disappear" (`product.md:65`). Counter-evidence is handled well. Alternatives survive only indirectly (contradicting claims, conflicting inferences, 5.4, EKR-06). There is no explicit statement that competing explanations of the same evidence are retained as peers. This is consistent with NG-4 (null hypothesis and Skeptic roles are not requirements) and I do not ask for more. I flag it as a thin spot to test in the proof of concept (Acceptance Criterion 3).
2. **Assumption-rooted support.** EKR-26 lets an inference chain ground in assumptions alone. The model makes derived support distinguishable from evidential support, but it never says that a claim whose entire support traces to assumptions should be visibly identifiable as assumption-rooted. A reader can trace it; nothing requires it to be surfaced. This is the most direct route by which "inherited assumptions" could still read as support. Advisory (A-3).
3. **Background knowledge (A-5).** A-5 distinguishes claims that need evidence from "background facts we're using (which may be assumed)" (`product.md:413-414`). The model draws the material/non-material line (4.2, 10.2) but gives background facts no explicit home. Under EKR-22 every relied-on unverified proposition is a recorded assumption, which may be heavy for ordinary background facts. A-5 is a Product Definition *assumption* to be validated, so leaving this for pilot evidence is acceptable. Advisory (A-4).
4. **Selective recording (EKR-18).** The duty to record contradicting information depends on actor conformance and is detectable only when it surfaces. The model says so openly. I regard this as the honest ceiling of a semantic model, not a defect.

### 2.2 Human authority and the self-approval/independence intent

I find **no weakening**.

- Section 3.1 (86-100) enumerates PR-01 to PR-28, ACT-01 to ACT-07, AUTH-G human-only, and the Moderator-role separation as preserved unchanged. EKR-04 downgrades any "validates" or "invalidates" asserted without authority to the nearest thing the actor may do (advisory finding, challenge, counter-evidence) rather than letting it stand as validation.
- Validation requires an explicit human AUTH-G act, independent of every recorded producer of the item accepted (8.3, EKO-11). Accumulated support, agent agreement, elapsed time, absence of objection, downstream completion, and verification are all named as non-validation (535). This matches the Restrictions list in `product.md:537-546`.
- Evaluator output is advisory in every row of 7.8 and EKR-20 (D8 / OQ-5 intact). Decisions without AUTH-G are recommendations (9.3).
- Where the model adds a human requirement (a human closer for dependents cited by a consequential decision, 10.8, EKR-38), it tightens rather than loosens HA-1.

**Residual self-approval risks.** Both are routed or recorded, but I want the Moderator to see them as product-intent risks and not only as housekeeping.

- **R-1 Correction versus supersession (UAD-04, 6.7, EKR-10, TRG-1).** Acceptance carries across a *correction* (meaning unchanged, no trigger) but not across a *supersession*. Whether meaning changed is a judgment (EKJ-09) that the model says is "attributable and challengeable" (337). The model does not say who makes that designation or whether the original acceptor is told. If the item's own producer makes it, a meaning-changing edit to an accepted item can retain independent acceptance and trigger nothing. This is the PR-16 failure (approving one's own output) arriving through item identity. EK-OQ-12 routes only the *representation* of identity across change (936), not this authority question. See Condition B-1.
- **R-2 Independence over cited items (9.5, EK-OQ-05).** STEP-01 defines independence relative to "the accepted item" but not which set that is when a decision cites items its own decision-maker produced. The model keeps every cited item's producers resolvable (EKR-32) and routes the set definition to STEP-03. Routing to STEP-03 is within STEP-02's Out of Scope (gate mechanics, `step-02.md:89`) and FR-4 leaves enforcement downstream (`product.md:310`). It is nevertheless the largest single self-approval gap left after STEP-02. See Advisory A-1.

### 2.3 Gaps, overreach, and hardening of open points

I weighed the model against `product.md`'s own cautions: Known Risk "protocol design becomes too complex" (mitigation: minimal protocol, expand on evidence, `product.md:425`), NG-1, NG-4, and FR-2/FR-6's statement that exact metadata and state mechanics are downstream.

**Hardening or extension that the Product Definition supports in intent**

- **Revalidation extended from decisions to all dependent items (UAD-06, 10.4, EKR-37).** WD-6 and FR-7 are worded for decisions. The model reaches claims, hypotheses, and inferences too. This follows the *intent* of WD-6 and the failure pattern (inherited assumptions) and is bounded by the material-dependency condition and by propagation through outcomes instead of transitive flooding (10.7). The Tech Lead confirmed it. I accept it as an intent-preserving extension, not overreach. It does raise burden; see Advisory A-5.
- **Presumed materiality (UAD-05, EKR-35).** Directly protects A-5 and PE-1 from a producer avoiding obligations by not calling a claim material. Supported.
- **Decision records must cite opposition (UAD-13, 9.4, EKR-30).** Grounded in FR-6 ("who challenged"), AH-3, and the failure pattern. It is the closest the model comes to gate mechanics and is hedged to record content only (634). Supported; STEP-03 should revisit.
- **Challenge targets extended to evidence and relationships (UAD-03).** Supported by the Human Authority Boundary's "disputing interpretation" and "analyze evidence" (`product.md:506`), adds no authority, and is declared rather than silent.

**Places the model leans toward hardening what `product.md` leaves open**

- **Per-item cumulative history (UAD-16, EKR-09), bidirectional dependency links (EKR-33), and dependency enumeration "on any conforming representation" (EKR-40, 11.4).** `product.md` leaves where provenance lives (OQ-8) and the metadata model downstream (FR-6, `product.md:325`). The model keeps these representation-neutral, so I do not call it a violation of NG-1. But EKR-40 and EKR-09 are *requirements on any representation*, which is stronger than "may be represented" and sits close to A-3/Appendix A ("Product Knowledge Ledger"). I read them as semantic requirements (what must be answerable), not a ledger. Advisory A-6 asks that STEP-05 not treat them as pre-decided.
- **Total volume.** 41 EKR rules, 20 EKO, 14 EKJ, 16 UADs, about 1,050 lines. Against the "start minimal" risk mitigation this is a lot. Each rule traces to a requirement or a principle, and the model separates "initial" from "catalog". Whether a real team can follow it is Evidence Expectation E-2 and Acceptance Criterion 3, which no step has tested yet. This is the main product-level risk I would carry forward.

I found **no requirement in the model that the Product Definition contradicts**, and no accepted-requirement status given to any Appendix A hypothesis (1.3, 62; consistent with NG-4).

### 2.4 The points in `qa.md` (D-05 a to d, D-08), from the product-intent view

I do not re-do QA. I give a view on whether each is a *product-intent* concern.

| Item | My view |
| --- | --- |
| **D-05a** Counter-evidence attached under AUTH-P or AUTH-A (5.2, 7.7) | **Not a concern; mildly positive.** STEP-01 itself is internally tense: the ACT-02 row says AUTH-P, the authority table (`protocol-semantics.md:138`) says AUTH-A may "seek and attach counter-evidence". The Product Definition gives non-producer assessors the power to search for counter-evidence and challenge (`product.md:506, 526-533`). Letting AUTH-A attach it lowers the barrier to surfacing dissent and adds no gate power. The model resolves a STEP-01 tension toward the Product Definition. It should be *declared* for process reasons (QA's point stands), but the substance is intent-aligned. Note the asymmetry: AUTH-A can attach counter-evidence but not supporting evidence. I consider that acceptable. |
| **D-05b** Who may withdraw, supersede, invalidate (10.5) | **Intent-consistent, with one watch-point.** Own-item withdrawal and supersession without acceptance are fine because both are triggers (TRG-1, TRG-4) and stay visible. Invalidating or superseding another actor's item needs acceptance authority, consistent with the Restrictions on closing disagreement without human authority (`product.md:546`). The watch-point is R-1 above (correction designation by a producer) and a producer withdrawing its own *counter-evidence*, which removes a contradiction from view though not from the record. Route both to STEP-03. |
| **D-05c** Human closer for dependents cited by a consequential decision (EKR-38, 10.8) | **Intent-aligned.** Adds a human requirement; none is removed. Supports HA-1. No concern. |
| **D-05d** Affirmative duty to record contradicting information (EKR-18) | **Intent-aligned and valuable.** It operationalizes AH-3 and the "counter-evidence disappears" failure. It is an actor duty the model cannot enforce and says so (1.4). Treat as a declared product-level normative choice, not an authority change. Recommend it be confirmed (by the Tech Lead or the Moderator) so the duty is not just implied. |
| **D-08** EKR-39 ("challenge takes visible effect immediately") vs 10.5 ("a challenge alone is not a trigger"); TRG-2 contradiction vs challenge cheapness | **Low-severity internal inconsistency; product intent is met on either reading.** WD-6 names "contradicted" as a trigger and WD-2/FR-5 require disagreement to stay visible. Both readings satisfy that. The unresolved point is whether the "visible effect" is exposure or a requirement, and whether a bare contradicting *claim* (cheap, like a challenge) should trigger a requirement on every dependent. The cost of leaving it is flooding that teaches teams to ignore requirements (a E-2/E-3 risk). It should be resolved in STEP-03 and not widen a requirement. EK-OQ-04 should be re-scoped to cover contradicting claims, not only challenges. |
| **D-06** Accepted domain terms disagree with the model ("Inference ... drawn from evidence"; "Challenge" targets) | **Product-intent relevant, moderately.** The model allows inference grounded in assumptions, which is the inherited-assumption channel. If the accepted term still says "from evidence", a reader may assume inferences always rest on evidence. The Moderator should reconcile this when disposing of the pending terms. Not blocking. |

### 2.5 Is any open question routed later that the Product Definition requires STEP-02 to settle?

**No.** I checked each of the 16 EK-OQs and the three PS-OQs routed to STEP-02 (13.1, 13.2).

- EK-OQ-01 (evidence categories and customer sufficiency) maps to Product OQ-2, which the Product Definition keeps open. FR-3's "required categories at gates" are gate-specific and so STEP-03 scope, and `step-02.md:91` explicitly excludes thresholds.
- EK-OQ-02, 06, 08, 10, 16 (validation authority, supersession authority, conditional-progression form, time-based triggers, non-decision closure authority) fall under Product OQ-4, OQ-7, FR-7's "exact form" and GR-7 as downstream. FR-7 requires the *properties* (unvalidated status, visible assumption, traceable dependents, no false validation) and the model supplies all four (8.4).
- EK-OQ-05 (independence set) and EK-OQ-04 (challenge response) sit in gate mechanics, which `step-02.md:89` assigns to STEP-03.
- EK-OQ-11 and 13 (state vs derived condition; disagreement as named condition) are the Product Definition's own OQ-3/OQ-8 and A-3, left open on purpose.

Two items are **not** product-required for STEP-02 but I rank as must-not-slip for STEP-03: EK-OQ-05 (Advisory A-1) and the correction-designation gap (Condition B-1, currently unrouted).

---

## 3. Conditions

### 3.1 Blocking for this sign-off

These need a Moderator-authorized record action. None requires a rewrite of `prod-w/evidence-knowledge-model.md`. I have not made, and was not permitted to make, any of these edits.

- **B-1. Route the correction-versus-supersession authority gap.** Record, as an open question for STEP-03 (a new EK-OQ, or a Moderator disposition note), the risk in R-1: who designates a post-acceptance change as a *correction*; whether the original acceptor must be notified; whether a correction designation on an accepted item by its own producer retains acceptance without independent review; and the related case of a producer withdrawing its own counter-evidence. Basis: FR-4 intent (self-approval must not be reachable through item identity), `product.md:309-310, 546`, model 6.7/EKR-10/EKJ-09.
- **B-2. Do not treat this sign-off as closing the STEP-02 gate record.** The Moderator should record, in a Moderator-owned artifact, how 3b and 3c are being treated for STEP-02: either ratify `qa.md` as 3b and this document as 3c retroactively, or record a STEP-02-specific GR-7 waiver (authorized human, unsatisfied requirement, rationale), as `qa.md` D-01 and the STEP-01 waiver wording require. My sign-off assumes that decision is the Moderator's. Basis: `qa.md` D-01, MW-OBS-012 (as cited by `qa.md`).

If B-1 is declined, my status would not be NOT_SIGNED_OFF; I would downgrade the sign-off to carry R-1 as an acknowledged, unrouted risk. B-2 is a process condition, not a content one.

### 3.2 Advisory (do not block sign-off)

- **A-1.** Treat EK-OQ-05 (independence set when a decision cites items produced by the decision-maker or its team) as first-priority entry work for STEP-03. It is the main residual self-approval hole.
- **A-2.** Resolve D-08 in STEP-03: state whether challenge and bare contradicting claims produce exposure, a requirement, or neither; widen EK-OQ-04 to cover contradicting claims.
- **A-3.** In STEP-03/04, consider whether a claim whose support traces entirely to assumptions should be identifiable as assumption-rooted in the record (thin spot 2.1.2).
- **A-4.** Observe in the proof of concept whether A-5's "background facts" collide with EKR-22 (every relied-on unverified proposition recorded). Record as pilot evidence (A-5 is a Product Definition assumption, `product.md:413`).
- **A-5.** Plan a burden check (E-2, Acceptance Criterion 3) specifically on the all-dependents revalidation scope and presumed materiality. Treat any proof-of-concept friction as evidence for narrowing, not as a reason to drop the intent.
- **A-6.** In STEP-05, do not treat EKR-09, EKR-33, or EKR-40 as selecting a ledger or a central state model (NG-1, NG-4, Appendix A).
- **A-7.** When disposing of the pending terms, reconcile "Inference" and "Challenge" with the model's wider use (D-06), and treat Validation, Invalidation, Material dependency, and Revalidation requirement as load-bearing terms needing explicit disposition (D-02). These are the Moderator's decisions.
- **A-8.** Confirm EKR-18 (affirmative recording duty) and the 10.5 withdraw/supersede/invalidate authority split as declared choices (D-05b, D-05d), by the Tech Lead or the Moderator, as `qa.md` recommends.
- **A-9.** Not a product-intent point, but noted: `qa.md` D-03/D-04/D-07 (stale observation text, missing MW-ADAPT-001 re-evaluation, stale delivery statement in model Section 15) are record items. I took no position on them beyond noting the model Section 15 statement ("No accepted ... Roadmap ... STEP-02 definition ... was modified", line 1045) is, per `qa.md`, inaccurate. I did not verify that through git.

---

## 4. Summary decision table

| Question | Answer |
| --- | --- |
| Meets the core problem in `product.md`? | Yes. Strongest on agent agreement, inference vs fact, counter-evidence, assumptions, and revalidation. Thin on alternatives, assumption-rooted support, and background knowledge. |
| Human authority and self-approval preserved? | Yes, unweakened. Two residual gaps: R-1 (correction designation) and R-2 (independence set, already routed). |
| Overreach? | None that contradicts the Product Definition. Extensions (all-dependents revalidation, presumed materiality, opposition citation) follow intent and are declared. Volume and burden are an untested product risk. |
| QA D-05 a to d, D-08? | D-05a/c/d intent-aligned; D-05b has a watch-point; D-08 low-severity inconsistency to resolve in STEP-03. |
| Open question required of STEP-02 but deferred? | None. |
| Status | SIGNED_OFF_WITH_CONDITIONS (B-1, B-2). |

---

*This sign-off is a recommendation to the MOD-W Moderator. Acceptance, gate treatment, waivers, and disposition of pending terms and observations remain the Moderator's decisions.*

MOD-W v5.0.1
